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Alexithymia and illness behaviour among 
female Indian outpatients with multiple 
somatic symptoms 
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ABSTRACT 
Sixty Indian muslim women outpatients with multiple somatic complaints of 
nonorganic origin were assessed for alexithymia and abnormal illness behaviour 
using the Toronto Alexithymia Scale (TAS) and the Illness Behaviour Assessment 
Schedule (IBAS). Alexithymia represented by TAS scores correlated best with the 
IBAS variables of communication of affect, somatic illness causal beliefs and denial. 
Correlation with other IBAS variables was modest to poor.There was no correlation 
of IBAS variables with age of patient, duration of illness or nature of diagnosis: 
somatoform disorder or anxiety and depressive disorders, The study showed that 
alexithymia and illness behaviour are overlapping constructs and confirmed the 
usefulness of TAS as an instrument to discriminate between patients with anxiety/ 
depressive disorders and somatoform disorders 
Key words: Alexithymia, Illness behaviour, Somatization 
Somatic symptoms with no physical 
explanation are often seen in the ciinica[ 
setting (Kscobar 1987). In non-western 
cultures especially, psychological distress is 
often communicated through multiple so-
matic complaints. Factors that have been 
considered to be contributorv to such an 
expression have included lower levels of 
emancipation (Narang and Aggarwal, 1971), 
social acceptance of such symptoms (Rastogi 
et al, 19"'6) and a perceptual style of bodily 
preoccupation as a dominant response to 
stress (Kicmman, 1982). Alexithymia, a 
cognitive-affective disturbance that affects 
the way in which individuals experience and 
express their emotions (Simeos, 1973) may 
be another factor contributing to a somatic 
experience and expression of psychological 
ill—health. Indeed studies of psychiatric 
patients (Bagby, Taylore & lison, 1988; Cox 
et al 1984 and normative population such 
as students (Bagby; Taylor & Ryan, 1986; 
Rodrigo, I.usiardo & Normey 1989), have 
revealed that alexithymic individuals score 
higher on various measures of somatization 
and hypochondriasis. Such individuals show 
a striking difficulty in recognizing and 
verbalizing their feelings and discriminating 
between emotions and bodily sensations 
(Nemia, Freyberger & Simeos, 1976). 
Patients with multiple somatic complaints 
(Bridges et al 1981; Bhandari, 1989) and 
hypochondriasis (Pilowsky & Spence, 1976) 
have also been found to demonstrate 
abnormal illness behaviour. Socio-cultural 
background has been reported to influence 
illness behaviour patterns such that Asian 
patients (Japanese) are more likely to display 
a fearful attitude toward their illness and 
health status than Caucasian (Australian) 
patients (Guo et al, 2000). Abnormal illness 
behaviour (AIB) arises out of Mechanic's 
view of how individuals perceive, interpret 
and behave when somatically distressed. 
Pilowsky and Spence, have described it as 
the "persistence of an inappropriate mode 
of perceiving, evaluating and acting (or not 
acting in relation to one's health, despite the 
fact that a doctor (or an appropriate social 
agent) has offered a reasonably lucid 
explanation of the nature of the illness and 
the appropriate course of management to 
be followed (based on a thorough 
examination and assessment of all parameters 
of functioning, including the use of special 
investigations wherever required) if any; 
with opportunities for discussion, 
negotiations and clarification based on 
adequate assessment of all biological, 
psychological, social and cultural factors. 
AIB consists of seven major dimensions: I) 
general hypochondriasis reflecting a fearful 
attitude towards illness, 2) disease conviction; 
a belief that there is something seriously 
wrong with one's body; 3) psychological 
versus somatic perception of illness, 4) 
affective inhibition; indicating difficulty in 
expressing personal feelings to others, 5) 
affective disturbance indicating 
acknowledgement of the presence of a 
negative mood state, 6) denial and 7) 
irritability 
As both alexithymia and AIB have been 
implicated as associated factors in patients 
with somatic complaints, we arranged to 
explore their relationship in a sample of 
Indian women with somatic complaints that 
were medically unexplained. We further 
wished to explore if membership of a 
particular diagnostic group - somatoform or 
anxiety/depression, was associated with 
differential patterns of illness behaviour, 
and possessor of differing service of 
alexithymia. also expected based upon the 
description by Pilowsky and Spence, that 
patients with a longer duration of illness 
exemplified by being followed-up by 
psychiatric services, would exhibit a more 
entrenched pattern of illness behaviour 
compared to patients that were newly reg-
istered. To control for aspects of socio-
cultural experience that can act as a potential 
confounder, subjects belonging to one 
particular religion with its own cultural 
nuances, i.e. Muslims, were included in the 
study. 
MATERIAL & METHODS 
Subjects 
Subjects comprised a consecutive series 
of Muslim female psychiatric outpatients of 
18-65 years of age presenting with five or 
(229) ALEXITHYMIA AND ILLNESS BEHAVIOUR 
more medically unexplained somatic com-
plaints, who were either new referrals to the 
psychiatry services (new group, n=30) or 
had been receiving treatment already (fol-
low-up group, n =30). These patients had 
been referred either by their general prac-
titioners, by medical and surgical specialists 
or were self referred. Those with an organic 
illness, psychosis or substance were excluded. 
The subjects were diagnosed by one of 
the authors (JS) using ICD-10 criteria 
(Freyberger 1977). The patients were later 
assessed by the other author (PSC) who was 
blind to initial diagnosis. Inclusion in the 
study depended on agreement in diagnosis 
between these two authors. Patients be-
longed to one of two diagnostic groups; 
somatoform disorders and anxiety or de-
pressive disorders. 
Instruments 
Besides collection of socio-demographic 
data, subjects completed the 26 item To-
ronro Alexithymia Scale -TAS (Talor, Ryan 
Bagby 1985) as a measure of alexythymia. 
TAS has demonstrated adequate internal 
consistency; good test-retest and split-half 
reliability and construct and criterion valid-
ity. The authors suggest that a score of 74 
and above is indicative of presence of 
alexithymia while a score of 58 and below 
negates its presence. AIB was assessed using 
the illness Behaviour Assessment Schedule 
- IBAS, a 19 item interviewer rated instru-
ment (Pilowsky & Spence, 1983). It has a 
high inter-rater reliability and concurrent 
validity studies of IBAS in relation to the 
Illness Behaviour Questionnaire, IBQ, have 
shown similar pattern of profile on both 
instruments (Piowsky & Spence, 1983). 
ANALYSIS 
Analysis focused upon the inter-group 
differences using Student's t-test with re-
spect to age, duration of symptoms and 
TAS scores. Relationship between IBAS 
items with variables such as age, duration 
of illness, diagnostic group and TAS score 
were analyzed by Pearson's correlation analy-
sis. The following IBAS items were selected 
as they collectively represent the seven 
primary dimensions on which illness behav-
iour is assessed by the IBQ (except for the 
general hypochondriasis factor). The items 
selected were: I) disease conviction -somatic, 
ii) disease conviction -psychological, iii) 
disease phobia, iv) preoccupation with so-
matic symptoms, v) illness causal beliefs, vi) 
communication of affective disturbance, vii) 
attribution of affective disturbance, vii) denial 
of life stressors and ix) displacement of life 
stresses onto somatic illness. 
RESULTS 
The mean age was 37.7 years (SD = +_ 
10 years) and the mean duration of symp-
toms 57.9 months (SD ± 53.7 months) for 
the entire group of sixty subjects. The mean 
TAS score for the sample was seventy-six. 
Twenty-seven patients scored above the cut-
off value of 74 on the TAS establishing a 
prevalence of alexithymia at 45% in this 
sample. 
Twelve ICD-10 diagnoses were attracted 
by the subjects. The three commonest 
diagnoses were somatization disorder (n=16), 
dysthymia (n=ll) and undifferentiated 
somatoform disorder (n=10). Overall there 
were 32 patients with a diagnosis of one 
or the other somatoform disorders and 28 
with one or the other anxiety or depressive 
TABLEI 
disorders. Abnormal illness behaviour as 
measured by the items of IBAS, was not 
associated with either the age of the patient, 
the length of experience of somatic 
symptoms or the diagnosis of the patient. 
Using Pearson's product moment correlation 
analysis, the correlation between the IBAS 
items and age ranged between -0.2 and + 
0.2. The figures were similar for duration 
of symptoms (r -0.12 to + 0.29) and 
diagnosis (r = -0.32 to 4 + 0.20). There was 
relatively better association between TAS 
scores and certain IBAS items although a 
majority of association can best be described 
as modest. TAS correlated best with 
inhibition in communication of affect (r = 
+ 0.5), followed by somatic illness causal 
beliefs (r + 0.44) and denial of life stresses 
(r = + 0.43). The figures were more modest 
for psychological disease conviction (r = + 
0.37) and displacement of life stresses on 
to somatic problems (r = + 0.36). The 
correlation with other IBAS items were 
relatively poor (r = + 0.23 to - 0.003). 
The only significant difference between 
patients belonging to either the somatoform 
group or the anxiety/depression group was 
that the patients belonging to the former 
displayed higher scores on TAS. The mean 
TAS score in the somaroform group was 
80.7 (S.D. + 17.6) while it was 70.7 (S.D.+ 
DIAGNOSIS  ICD-10 code n(%) 
Somatization disorder 
Somatoform autonomic dysfunction 
Persistent somatoform pain disorder 
Somatoform disorder - undifferentiated 
Mild depressive episode - without somatic symptoms 
Moderate depressive disorder with somatic symptom 
Recurrent depressive episode 
- current episode mild with somatic symptoms 
Recurrent depressive episode 
- current episode moderate with somatic symptoms 
Dysthymia 
Panic disorder 
Generalized anxiety disorder 
Agoraphobia with panic disorder 
SOMATOFORM DISORDERS 
DEPRESSIVE/ANXIETY DISORDERS 
F45.0 
F45.3 
F45.4 
F45.1 
F32.00 
F32.10 
16 (27) 
1 (2) 
5 (8) 
10 (17) 
1 (2) 
1 (2) 
F33.01  2 (3) 
F32.ll 
F34.1 
F41.0 
F41.1 
F40.01 
4 (7) 
11 (18) 
6 (10) 
2 (3) 
1 (2) 
32 (56.7) 
28 (44.3) 
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TABLE 2 : Old group. New group. Significance ;Age in years Duration of symptoms 
in months TAS score 
(n=30) (n=30) P <0.05 
mean, S.D. mean, S.D. 
36.6,+ 8.8 38.9 + 11.0 Not Significant 
31.5, + 5.2 84.3 + 11.0 p=-0.0001 
71.0, 14.7 81.0, 19.3 Not Significant 
TABLE 3 : Age in years Duration of symptoms in TAS score 
Somatoform Anxiety/depression Significance 
Mean, S.D. Mean, S.D. P < 0.05 
39.5 + 10.7 35.7 + 8.9 Not Significant 
66.8 + 62 47.4 + 40.5 Not Significant 
80.7 + 17.6 70.7 + 16.7 P = 0.027 
TABLE 4 : Correlation coefficients for IBAS items with TAS scores and diagnostic 
category. 
Correlation coefficient, r 
TAS 
score 
IBAS items 
Disease conviction - somatic 
Disease conviction - psychological 
Disease phobia 
Disease preoccupation 
Illness causal beliefs- somatic 
Communication of affect 
Attribution of affective disturbance 
Denial 
Displacement-
Somatoform 
disorder 
- 0.357 -
+ 0.370 
+ 0.011 
- 0.003 
+ 0.437 
+ 0.503 
+ 0.235 
+ 0.431 
+ 0.364 
t- 0.198 
- 0.264 
+ 0.189 
+ 0.149 
- 0.099 
- 0.328 
- 0.234 
- 0.246 
- 0.233 
16.7) in the anxiety/depression group. 
Nineteen parents of the somatoform group 
scored above the cut-off score of 74 
indicating the presence of alexithymia cat-
egoncalh; whilst only eight patients from 
the anxiety/depression group did so. These 
two groups of patients did not differ 
significantly in terms of age or duration of 
symptoms experienced although there were 
trends for those with a diagnosis of 
somatoform disorder to be older (39.5 
vcars) and have a longer duration of illness 
(66.8 months) than those who were diag-
nosed with anxiety/depression (35.7 years 
and 4"\4 months) respectively. 
There was no difference between the 
follow-up and new groups with respect to 
belonging to a particular diagnostic group. 
Each group included 16 patients with a 
diagnosis of somatoform disorder and 14 
patients with one of the anxiety or depressive 
disorders. There was an over representation 
of patients with somatization disorder (n= 13) 
in the follow-up group as opposed to new 
group (n=3). However, there was an excess 
of diagnosis of undifferentiated somatoform 
disorder in the new group (n=9) in contrast 
to the follow-up group (n=l). Dysthymic 
patients were found more commonly in the 
follow-up group whilst there were similar 
numbers of patients with this diagnosis and 
that of moderate depression with somatic 
symptoms in the new group. 
There was no significant difference in the 
mean age of patients in the follow-up and 
new groups although there was a trend for 
patients in the follow-up group to be older. 
The mean age of patients following up was 
38.9 years while that of the new group was 
36.6 years. The follow-up group had a 
significandy longer duration of symptoms 
than the new group, which was to be 
expected. The mean TAS score was 
significandy higher in the follow-up group 
(81.0 as opposed to 71.0 in the new group) 
suggesting higher rates of alexithymia on a 
dimensional scale. Using the cut-off score 
of 74 to discriminate between those with 
and without alexithymia, eighteen patients 
on the follow-up group scored above this 
threshold whilst only nine patients from the 
new group did so. Thus, even at a categorical 
level there was an overrepresentation of 
alexithymia in the follow-up group com-
pared with the new group. 
DISCUSSION 
The prevalence of alexithymia in a sam-
ple of female Indian outpatients with 
multiple somatic symptoms of non-organic 
origin is 45% (27 out of 60). It is com-
parable to the prevalence rates found in a 
sample of psychiatric outpatients (Taylor et 
al, 1992) and in a of somatizing patients 
(Cox et al, 1984). However individual TAS 
scores in this sample was high with a mean 
score of 76. 
The mean TAS score was higher in 
patients with a longer duration of illness. 
It has been suggested that alexithymia is a 
primary personality trait, the possession of 
which predisposes patients to longer lasting 
somatic illnesses (Salmiren et al 1984). 
Alternatively; patients who have a longer 
duration of a somatic illness may develop 
alexithymic characteristics, a secondary state 
phenomenon, due to associated depression 
and stress (Freyberger, 1977). 
It is not possible to definitively state with 
confidence whether the alexithymia 
determined in this study is a primary or a 
secondary' phenomenon. However, it is more 
likely that the construct is a primary feature 
in other patients as those with anxiety and 
depression displayed a mean TAS score that 
was lower than the mean for the entire 
group ( 71 versus 76) and indeed signifi-
candy lower than those with a somatoform 
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disorder diagnosis (71 versus 81), suggesting 
that being anxious or depressed perhaps did 
not influence the presence of alexitliymia 
to any significant degree. The lack of 
correlation between TAS score and affective 
disturbance dimension of IBAS further 
strengthens this conclusion. 
Patients with somatoform disorders 
displayed a significandy higher mean TAS 
score in comparison to those with anxiety 
or depression suggests that TAS may be an 
useful instrument to employ in patients that 
present with multiple somatic compliant. It 
has clearly demonstrated the ability to dis-
criminate between these two diagnostic 
groups among patients who present with 
multiple somatic complaints of a non-
organic origin that may appear to represent 
a homogenous disorder, which in reality is 
not always the case. 
Presence of alexithymia correlated with 
a longer duration of illness experience 
suggesting that it is vitally important to 
determine personality factors, such as 
alexithymia, such that management strate-
gies could incorporate these issues. Such a 
process would hopefully allow a more holistic 
approach to patients who present in this 
manner. 
The age of a patient, having a longer 
duration of somatic illness and the nature 
of diagnosis do not appear to alter a 
person's way of perceiving, interpreting and 
behaving when somatically distressed as 
illustrated by the lack of correlation be-
tween these variables with IBAS items. Our 
results seem to indicate that it is the 
presence of alexithymic characteristics alone 
that impact upon dimensions of illness 
behaviour. The strongest correlations of 
TAS scores were with inhibition of 
communication of affective disturbance, 
somatic illness causal beliefs and denial of 
life stresses. There are valid reasons for such 
correlations. The literal Greek translation of 
the word alexithymia is the lack of (a: lack 
of) words (lexos: words) for emotions 
(thymos: emotions). This feature of the 
construct is similar to the IBAS dimension 
of inhibition of affective disturbance which 
implies a lack of verbal endorsement of 
affective disturbance that the patient is 
experiencing. Alexithymia also relates to a 
difficulty in discriminating between emo-
tional states and bodily concerns (Nemiah, 
Freyberger & Simeos, 1976. Thus somatizing 
may be a coping strategy recruited by 
alexithymic individuals to deal with undif-
ferentiated emotional arousal; a form of 
acting out behaviour (Nemiah, Freyberger & 
Simeos, 1976 Robbins, 1989). The alexithymic 
individuals focus on somatic concerns and 
external events would prevent her from 
expressing die life stresses that maybe 
contributing to her distress in the first 
instance. 
Wise et al (1990) have reported that the 
constructs of alexithymia and illness behav-
iour overlap in that more alexithymic sub-
jects endorse more disease conviction, hy-
pochondriacal concerns, affective inhibition, 
affective disturbance, irritability. Our results 
support these findings to a degree. Whilst 
die results confirm that there is overlap 
between alexithymia and affective inhibition 
and somatic illness causal beliefs, they do 
not suggest that more alexithymic subjects 
displayed more affective disturbance and 
irritability. Further, Wise et al, did not find 
a correlation between TAS scores and denial, 
a finding evident in this study, albeit at a 
modest degree. This difference is possibly 
a consequence of Wise et al, assessing a 
heterogeneous population of with varying 
degrees of illness severity that included 
inpatients and outpatients as well as non-
psychiatric patients. The use of a narrow 
inclusion criterion in this study could have 
led to the inclusion of subjects that were 
qualitatively very different from the sample 
in the Wise study. 
The finding that TAS scores correlated 
modestly with a psychological disease con-
viction, although surprising, is not incom-
patible. These patients had been referred to 
psychiatrists only after they had been ex-
tensively investigated for the cause of somatic 
compliant. That they agreed to consult 
psychiatrists and continued to do so during 
follow-up would suggest, there was an 
acceptance on the part of the patients that 
their symptoms may have a psychological 
basis. By the same argument it is possible 
that our patients were primed through prior 
medical contact, of the link between stress 
and somatic complaints such that they were 
in denial of it during later inquiry during 
the study. Alexithymic individuals have been 
found to be prone to symptoms of emo-
tional turmoil as well as to somatization 
because they are ill equipped Psychologically 
(Lane & Schwadz, 1987; Krystal, 1988). 
This is also consistent with empirical 
evidence of moderately high correlations 
among anxiety, depression and somatic 
symptoms in both normal subjects and 
various patient groups Indeed, the fact that 
almost half the patients experienced an 
anxiety or a depressive disorder is a testimony 
to this. 
In conclusion, the constructs of 
alexithymia and abnormal illness behaviour 
appear to overlap only to a limited extent 
in a population of Muslim Indian women 
with multiple somatic complaints of a non-
organic origin. Illness behaviour in this 
group is not influenced by either the age 
of the patient or by the nature of their 
diagnosis. Further, a longer duration of 
illness does not appear to influence illness 
behaviour. Possession of the alexithymia 
trait is the only factor influencing a patient's 
illness behaviour. This finding has implica-
tions for both assessment as well as man-
agement of this patient group. The Toronto 
Alexithymia Scale is an appropriate instru-
ment to determine alexithymia and its use 
would ostensibly lead to development ot 
optimum management strategies by includ-
ing personality issues in the final equation. 
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